Skip to main content

Peer Review reports

From: The clinical significance of plasma sCD25 as valuable biomarker for progression and prognosis of tuberculosis

Original Submission
25 Apr 2023 Submitted Original manuscript
7 Jun 2023 Reviewed Reviewer Report
17 Jun 2023 Reviewed Reviewer Report
10 Aug 2023 Author responded Author comments - Meiying Wu
Resubmission - Version 2
10 Aug 2023 Submitted Manuscript version 2
10 Aug 2023 Author responded Author comments - Meiying Wu
Resubmission - Version 3
10 Aug 2023 Submitted Manuscript version 3
22 Aug 2023 Reviewed Reviewer Report
15 Sep 2023 Reviewed Reviewer Report
9 Oct 2023 Author responded Author comments - Meiying Wu
Resubmission - Version 4
9 Oct 2023 Submitted Manuscript version 4
11 Oct 2023 Author responded Author comments - Meiying Wu
Resubmission - Version 5
11 Oct 2023 Submitted Manuscript version 5
29 Oct 2023 Author responded Author comments - Meiying Wu
Resubmission - Version 6
29 Oct 2023 Submitted Manuscript version 6
29 Oct 2023 Author responded Author comments - Meiying Wu
Resubmission - Version 7
29 Oct 2023 Submitted Manuscript version 7
30 Oct 2023 Author responded Author comments - Meiying Wu
Resubmission - Version 8
30 Oct 2023 Submitted Manuscript version 8
Publishing
7 Nov 2023 Editorially accepted
22 Jan 2024 Article published 10.1186/s12879-023-08798-5

You can find further information about peer review here.

Back to article page